ActiveMumbai, MaharashtraSince 1997

Hab Pharmaceuticals and Research Limited

Follow

Set up in 1997 in Mumbai. It has pledged its assets against loans of up to ₹58.58 crore from 2 lenders.

CINU99999MH1997PLC105340
Get its revenue and profit

From its annual accounts, which Entiva gets and reads for you.

Ask your favourite AI

Get a plain-English summary of this company.

29 years at a glance

Loans against its assets, and when today's people joined

199820002002200420062008201020122014201620182020202220242026LOANS AGAINST ITS ASSETSTODAY'S PEOPLE, WHEN THEY JOINEDRegistered as a companyBank of Baroda, up to ₹5.43 crore, 19 Aug 1999 to 13 Mar 2014Bank of Baroda, up to ₹1.11 crore, 20 Aug 1999 to 13 Mar 2014Bank of Baroda, up to ₹10 lakh, 20 Aug 1999 to 13 Mar 2014Bank of Baroda, up to ₹2.08 lakh, 13 Mar 2002 to 3 Jul 2014Bank of Baroda, up to ₹15 lakh, 9 Aug 2002 to 13 Mar 2014Bank of Baroda, up to ₹5.43 crore, 19 Oct 2006 to 13 Mar 2014Bank of Baroda, up to ₹25 lakh, 20 Aug 2008 to 13 Mar 2014Bank of Baroda, up to ₹8.15 lakh, 2 May 2012 to still openYes Bank Limited, up to ₹16.07 crore, 8 Nov 2013 to 22 Mar 2024Yes Bank Limited, up to ₹16.48 crore, 21 Mar 2014 to 22 Mar 2024Deutsche Bank Ag, up to ₹1.43 crore, 14 Sept 2017 to 10 Jan 2024Yes Bank Limited, up to ₹97.94 lakh, 19 Dec 2020 to 22 Mar 2024Standard Chartered Bank, up to ₹10 crore, 2 Feb 2023 to 12 Dec 2023Kotak Mahindra Bank Limited, up to ₹58.5 crore, 8 Sept 2023 to still open
Loan still openLoan paid offSomeone joined, and is still there
  • 1997Registered as a company on 22 Jan 1997.
  • 2023Its biggest loan against assets, ₹58.5 crore with Kotak Mahindra Bank Limited, is still open.

Who runs it

This page does not list its directors yet. Open the company in Entiva to see who runs it on MCA's register today.

Who has lent to it

₹58.58 crorein loans backed by its assets, from 2 lenders

  • Kotak Mahindra Bank Limited₹58.5 crore

    Open, taken out 8 Sept 2023

  • Bank of Baroda₹8.15 lakh

    Open, taken out 2 May 2012

12 earlier loans, now paid off
  • Standard Chartered Bank2 Feb 2023 to 12 Dec 2023₹10 crore
  • Yes Bank Limited19 Dec 2020 to 22 Mar 2024₹97.94 lakh
  • Deutsche Bank Ag14 Sept 2017 to 10 Jan 2024₹1.43 crore
  • Yes Bank Limited21 Mar 2014 to 22 Mar 2024₹16.48 crore
  • Yes Bank Limited8 Nov 2013 to 22 Mar 2024₹16.07 crore
  • Bank of Baroda20 Aug 2008 to 13 Mar 2014₹25 lakh
  • Bank of Baroda19 Oct 2006 to 13 Mar 2014₹5.43 crore
  • Bank of Baroda9 Aug 2002 to 13 Mar 2014₹15 lakh
  • Bank of Baroda13 Mar 2002 to 3 Jul 2014₹2.08 lakh
  • Bank of Baroda20 Aug 1999 to 13 Mar 2014₹1.11 crore
  • Bank of Baroda20 Aug 1999 to 13 Mar 2014₹10 lakh
  • Bank of Baroda19 Aug 1999 to 13 Mar 2014₹5.43 crore

What its filings add

Hab Pharmaceuticals and Research files these with the registrar. Entiva fetches and reads them for you.

  • Every year · AOC-4

    Revenue, profit and the balance sheet

    Its financial statements, year by year.

  • Every year · MGT-7

    Who owns it

    Its shareholders, and how much each one owns.

  • Each loan · CHG-1

    Each loan in detail

    The terms, and which assets back each loan.

  • ChatGPT · Claude

    Ask questions about them

    Connect Entiva to your assistant and ask in plain English.

    “How did Hab Pharmaceuticals and Research's revenue change over the last three years?”

Same line of business

Registered for the same kind of business, closest in size first

Keep an eye on Hab Pharmaceuticals and Research

  • Free

    Follow the company

    An email when it files, or its directors or loans change.

  • Free

    Follow its people

    Hear when a director joins another company.

  • Free

    Map the network

    See every company its people connect to.

  • Per order

    Read the filings

    Accounts, owners and loans, in Entiva or your AI assistant.

Create a free account

No card needed to follow.

The details on this page come from public records, including MCA's register of companies as Entiva read it on . Things may have changed since. A loan amount is the most the lender can claim against the company's assets, not what is still owed.